Orient EuroPharma Co., Ltd. (4120.TWO)

TWD 46.3

(-1.38%)

Operating Income Summary of Orient EuroPharma Co., Ltd.

  • Orient EuroPharma Co., Ltd.'s latest annual operating income in 2023 was 84.55 Million TWD , up 240.5% from previous year.
  • Orient EuroPharma Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 8.89 Million TWD , up 127.95% from previous quarter.
  • Orient EuroPharma Co., Ltd. reported an annual operating income of -259 Million TWD in 2022, down -348.35% from previous year.
  • Orient EuroPharma Co., Ltd. reported an annual operating income of -57.76 Million TWD in 2021, down -120.32% from previous year.
  • Orient EuroPharma Co., Ltd. reported a quarterly operating income of -17.77 Million TWD for 2024 Q1, down -103.78% from previous quarter.
  • Orient EuroPharma Co., Ltd. reported a quarterly operating income of 470.72 Million TWD for 2023 Q4, up 60141.71% from previous quarter.

Annual Operating Income Chart of Orient EuroPharma Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of Orient EuroPharma Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 84.55 Million TWD 240.5%
2022 -259 Million TWD -348.35%
2021 -57.76 Million TWD -120.32%
2020 284.23 Million TWD -15.51%
2019 336.41 Million TWD 0.0%

Peer Operating Income Comparison of Orient EuroPharma Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 4.689%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 44.939%
Easywell Biomedicals, Inc. -162.73 Million TWD 151.957%
TTY Biopharm Company Limited 1.37 Billion TWD 93.839%
Synmosa Biopharma Corporation 614.74 Million TWD 86.246%
Center Laboratories, Inc. -79.26 Million TWD 206.673%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -313.75%
Orient Pharma Co., Ltd. 27.75 Million TWD -204.666%
InnoPharmax Inc. -64.83 Million TWD 230.406%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 19.908%
Excelsior Biopharma Inc. -81.12 Million TWD 204.223%
DV Biomed Co., Ltd. 173.54 Million TWD 51.279%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 108.391%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 87.848%
UniPharma Co., Ltd. -27.3 Million TWD 409.665%
Anxo Pharmaceutical Co., Ltd. 53.15 Million TWD -59.077%
Alar Pharmaceuticals Inc. 385.52 Million TWD 78.068%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 56.882%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 285.06%
Bioray Biotech Co., Ltd -19.33 Million TWD 537.401%
TSH Biopharm Corporation Limited 63.63 Million TWD -32.884%